Aspect Biosystems is a biotechnology company pioneering bioprinted tissue therapeutics with a full-stack platform that combines AI-powered bioprinting, computational design tools, therapeutic cells, and advanced biomaterials to create allogeneic tissue therapeutics. The company focuses on regenerative medicine and developing implantable tissues to replace, repair, or augment biological functions for metabolic and endocrine diseases. Its work spans technology development, therapeutic programs, and partnerships with pharma and biotech leaders to bring tissue-based therapies to the clinic, with a global, collaborative approach.